| Predicted Trait | |
| Reported Trait | Melanoma |
| Mapped Trait(s) | melanoma (EFO_0000756) |
| Additional Trait Information | Genes involved in the pigment pathway |
| Score Construction | |
| PGS Name | PRS_melanoma_pigment.pathway |
| Development Method | |
| Name | Genome-wide significant variants |
| Parameters | SNPs with previously confirmed melanoma risk in genes involved in the pigmentation pathway |
| Variants | |
| Original Genome Build | NR |
| Number of Variants | 31 |
| Effect Weight Type | log(OR) |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000151 |
| Citation (link to publication) | Cust AE et al. J Invest Dermatol (2018) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 36,077 individuals (100%) |
| PGS Evaluation | European: 100% 2 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST003061 Europe PMC: 26237428 |
36,077 individuals | European | NR |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM001830 | PSS000927| European Ancestry| 1,035 individuals |
PGP000151 | Cust AE et al. J Invest Dermatol (2018) |
Reported Trait: Melanoma | OR: 1.71 [1.49, 1.96] | — | Odds Ratio (OR, top vs. bottom tertile): 3.11 [2.21, 4.36] Odds Ratio (OR, top vs. bottom decile): 5.75 [3.09, 10.72] |
Age, sex, recruitment city, self-reported European ancestry | — |
| PPM001831 | PSS000928| European Ancestry| 1,460 individuals |
PGP000151 | Cust AE et al. J Invest Dermatol (2018) |
Reported Trait: Melanoma | OR: 1.66 [1.49, 1.86] | — | Odds Ratio (OR, top vs. bottom tertile): 2.94 [2.23, 3.88] Odds Ratio (OR, top vs. bottom decile): 7.0 [4.12, 11.88] |
Age, sex, self reported European ancestry | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS000927 | Cases include invasive cutaneous melanoma diagnoses between ages 18 and 39 years | — | [ ,
40.0 % Male samples |
— | European | — | AMFS | — |
| PSS000928 | Cases include histopathologically confirmed invasive melanoma cases in patients between 18 and 82 years. | — | [ ,
40.0 % Male samples |
— | European | — | LMC | — |